PMDA — authorised 22 November 2007
- Marketing authorisation holder: Janssen Pharmaceutical K.K.
- Status: approved
PMDA authorised Prezista on 22 November 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 22 November 2007.
Janssen Pharmaceutical K.K. holds the Japanese marketing authorisation.